Wolverine Trading’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16M | Sell |
164,800
-58,600
| -26% | -$6.07M | 0.01% | 693 |
|
|
2025
Q2 | $23.8M | Buy |
223,400
+100,100
| +81% | +$10.1M | 0.02% | 421 |
|
|
2025
Q1 | $12.3M | Sell |
123,300
-19,700
| -14% | -$1.98M | 0.01% | 563 |
|
|
2024
Q4 | $12.8M | Sell |
143,000
-93,900
| -40% | -$8.27M | 0.01% | 664 |
|
|
2024
Q3 | $19.7M | Buy |
236,900
+156,300
| +194% | +$12.3M | 0.02% | 444 |
|
|
2024
Q2 | $6.21M | Sell |
80,600
-2,800
| -3% | -$205K | 0.01% | 857 |
|
|
2024
Q1 | $5.71M | Sell |
83,400
-64,300
| -44% | -$4.13M | 0.01% | 932 |
|
|
2023
Q4 | $8.54M | Sell |
147,700
-18,500
| -11% | -$988K | 0.01% | 794 |
|
|
2023
Q3 | $8.78M | Buy |
166,200
+83,400
| +101% | +$4.37M | 0.01% | 680 |
|
|
2023
Q2 | $4.41M | Buy |
82,800
+52,200
| +171% | +$2.73M | 0.01% | 982 |
|
|
2023
Q1 | $1.52M | Sell |
30,600
-130,800
| -81% | -$6.16M | ﹤0.01% | 1573 |
|
|
2022
Q4 | $7.47M | Sell |
161,400
-22,000
| -12% | -$953K | 0.01% | 716 |
|
|
2022
Q3 | $7.21M | Sell |
183,400
-40,700
| -18% | -$1.63M | 0.01% | 689 |
|
|
2022
Q2 | $8.47M | Buy |
224,100
+36,100
| +19% | +$1.47M | 0.01% | 583 |
|
|
2022
Q1 | $8.4M | Sell |
188,000
-110,500
| -37% | -$4.79M | 0.01% | 771 |
|
|
2021
Q4 | $12.8M | Buy |
298,500
+97,800
| +49% | +$4.11M | 0.02% | 613 |
|
|
2021
Q3 | $8.81M | Buy |
200,700
+82,500
| +70% | +$3.65M | 0.01% | 891 |
|
|
2021
Q2 | $5.11M | Sell |
118,200
-17,300
| -13% | -$728K | 0.01% | 1122 |
|
|
2021
Q1 | $5.28M | Sell |
135,500
-68,500
| -34% | -$2.59M | 0.01% | 1069 |
|
|
2020
Q4 | $7.25M | Buy |
+204,000
| New | +$7.35M | 0.01% | 852 |
|
|
2020
Q3 | – | Sell |
-139,400
| Closed | -$4.83M | – | 4524 |
|
|
2020
Q2 | $4.83M | Buy |
139,400
+60,600
| +77% | +$2.18M | 0.01% | 825 |
|
|
2020
Q1 | $2.49M | Buy |
78,800
+18,300
| +30% | +$715K | 0.01% | 1176 |
|
|
2019
Q4 | $2.72M | Sell |
60,500
-35,800
| -37% | -$1.5M | 0.01% | 1584 |
|
|
2019
Q3 | $3.88M | Buy |
+96,300
| New | +$4.08M | 0.01% | 1009 |
|
|
2019
Q2 | – | Sell |
-66,600
| Closed | -$2.56M | – | 4432 |
|
|
2019
Q1 | $2.56M | Sell |
66,600
-124,100
| -65% | -$4.74M | 0.01% | 1332 |
|
|
2018
Q4 | $6.61M | Sell |
190,700
-32,600
| -15% | -$1.18M | 0.02% | 648 |
|
|
2018
Q3 | $8.6M | Buy |
223,300
+159,400
| +249% | +$5.57M | 0.02% | 634 |
|
|
2018
Q2 | $1.75M | Hold |
63,900
| – | – | ﹤0.01% | 1714 |
|
|
2018
Q1 | $1.75M | Sell |
63,900
-4,300
| -6% | -$117K | ﹤0.01% | 1714 |
|
|
2017
Q4 | $1.69M | Buy |
68,200
+13,100
| +24% | +$361K | 0.01% | 1685 |
|
|
2017
Q3 | $1.61M | Sell |
55,100
-9,500
| -15% | -$262K | 0.01% | 1494 |
|
|
2017
Q2 | $1.8M | Buy |
+64,600
| New | +$1.71M | 0.01% | 1301 |
|
|
2017
Q1 | – | Sell |
-115,700
| Closed | -$2.5M | – | 4292 |
|
|
2016
Q4 | $2.5M | Sell |
115,700
-33,700
| -23% | -$735K | 0.01% | 1176 |
|
|
2016
Q3 | $3.48M | Buy |
149,400
+37,200
| +33% | +$887K | 0.02% | 945 |
|
|
2016
Q2 | $2.58M | Buy |
+112,200
| New | +$2.43M | 0.01% | 946 |
|
Other funds holding BSX
Wolverine Trading's BSX Position: Q3 2025 in Review
Wolverine Trading increased its Boston Scientific (BSX) stake by 205% in Q3 2025, buying an estimated $777K and bringing the position to 11,165 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.
Wolverine Trading first reported a position in BSX in Q2 2016 and has held it in 29 quarters since. The position peaked at $5.37M in Q4 2019. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Wolverine Trading held 11,165 shares of Boston Scientific worth $1.08M as of Q3 2025.
- Wolverine Trading bought 7,499 Boston Scientific shares in Q3 2025, an estimated $777K.
- Boston Scientific made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2816 holding.
- Wolverine Trading first reported a position in Boston Scientific in Q2 2016 and has held it in 29 quarters since.
- Wolverine Trading's Boston Scientific position peaked at $5.37M in Q4 2019.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.